The diagnosis of type I tyrosinemia is supported by the demonstration of 4-oxo-6-hydroxyheptanoic acid in urine, a strongly decreased but measurable FAH enzyme activity in liver tissue and fibroblasts and the demonstration of a novel mutation in the FAH gene (Ala35Thr). The gene discussed is FAH; the disease is tyrosinemia.